Raúl Chávez

Raúl Chávez

Auto-generated profile, based on publicly available information

Raúl Chávez

Laboratorio de Inmunologia, Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autónoma de México, P.O. Box 70159, 04510, México

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2009 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
LCL Chávez-Galán
L Chávez-Galán
MAM C Arenas-Del Angel
M C Arenas-Del Angel
EZEdgar Zenteno
Edgar Zenteno
RCR Chávez
R Chávez
RLRicardo Lascurain
Ricardo Lascurain

4 June 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
ADAlfonso Diaz
Alfonso Diaz
DLDaniel Limon
Daniel Limon
RCRaúl Chávez
Raúl Chávez
EZEdgar Zenteno
Edgar Zenteno
JGJorge Guevara
Jorge Guevara
Amyloid-β (Aβ)25-35 is able to cause memory impairment and neurodegenerative events. Recent evidence has shown that the injection of Aβ25-35 into the temporal cortex (TCx) of rats increases the inflammatory response; however, it is unclear how the inflammatory process could be involved in the progression of Aβ25-35 toxicity. In this study we investigated the role of inflammation in the neuronal damage and spatial memory impairment generated by Aβ25-35 in rat TCx using immunohistochemistry, ELISA, and a behavioral test in the radial maze. Our findings show that Aβ25-35 -injection into the TCx induced a reactive gliosis (GFAP and CD11b-reactivity) and an increase of pro-inflammatory cytokines (IL-1β, IL-6, IL-17, and TNF-α) in the TCx and the hippocampus at 5, 15, and 30 days after injection. Thirty days after Aβ25-35 injection, we observed that the inflammatory reaction probably contributed to increase the immunoreactivity of inducible nitric oxide synthase and nitrite levels, as well as to the loss of neurons in TCx and hippocampus. Behavioral performance showed that the neurodegeneration evoked by Aβ25-35 delayed acquisition of learning and impaired spatial memory, because the Aβ25-35-treated animals showed a greater number of errors during the task than the control group. Previous administration of an interleukin receptor antagonist (IL-1ra) (10 and 20 μg/μL, into TCx), an anti-inflammatory agent, suppressed the Aβ25-35-induced inflammatory response and neurodegeneration, as well as memory dysfunction. This study suggests that the chronic inflammatory reaction could contribute to the progression of Aβ25-35 toxicity and cause cognitive impairment.

1 October 1998 in International Journal of Immunopharmacology
Verified
Journal Article
Closed access
SES. Estrada-Parra
S. Estrada-Parra
ANA. Nagaya
A. Nagaya
ESE. Serrano
E. Serrano
ORO. Rodriguez
O. Rodriguez
VSV. Santamaria
V. Santamaria
IEI. Estrada-Garcia
I. Estrada-Garcia

15 December 2003 in Immunology
Verified
Journal Article
Open access
PDF file
MJMaria C Jiménez-Martínez
Maria C Jiménez-Martínez
MLMarisela Linares
Marisela Linares
RBRenata Báez
Renata Báez
LMLuis F. Montaño
Luis F. Montaño
SMSalvador Martínez‐Cairo
Salvador Martínez‐Cairo
RLRicardo Lascurain
Ricardo Lascurain
Summary: In some chronic pathological conditions, antigen persistence activates and expands the CD4+ CD57+ T‐cell subset. The host immune response against tuberculosis infection is maintained through the continuous presence of antigen‐stimulated effector/memory helper T cells. To determine whether CD4+ CD57+ T cells were also expanded in human tuberculosis, we analysed (by flow cytometry) the phenotype of peripheral blood CD4+ T cells from 30 tuberculosis patients and 30 healthy controls. We observed a significant increase in the CD4+ CD57+ T‐cell subset in tuberculosis patients in comparison to healthy controls (P < 0·001). Most CD4+ CD57+ T cells exhibited a CD28− CD45RO+ CD62L− phenotype, which is associated with memory cells. In vitro, a higher number of antigen‐stimulated CD4+ CD57+ T cells produced intracellular interferon‐γ and interleukin‐4 compared with antigen‐stimulated CD4+ CD57− T cells (P < 0·001). These findings suggest that the majority of CD4+ CD57+ T cells correspond to a phenotype of activated memory T cells.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ADAlfonso Diaz
Alfonso Diaz
CEClaudia Escobedo
Claudia Escobedo
STSamuel Treviño
Samuel Treviño
RCRaúl Chávez
Raúl Chávez
GLGustavo Lopez-Lopez
Gustavo Lopez-Lopez
GMGuadalupe Muñoz-Arenas
Guadalupe Muñoz-Arenas
An important worldwide health problem as the result of current lifestyle is metabolic syndrome (MS). It has been shown that MS induced by a high‐calorie diet (HCD) in rats produces cognitive deterioration in the novel object recognition test (NORt) and decreases synaptic connections and dendritic order in the hippocampus and temporal cortex. However, it is unknown whether MS induced by an HCD participates in the cognitive process observed with the injection of Aβ1–42 into the hippocampus of rats as a model of Alzheimer disease (AD). The induction of MS in rats produces a deterioration in NORt; however, rats with MS injected with Aβ1–42 show a major deterioration in the cognitive process. This event could be explained by the increment in the oxidative stress in both cases studied (MS and Aβ1–42): together, the hippocampus and temporal cortex produce an enhancer effect. In the same way, we observed an increment in interleukin‐1β, TNF‐α, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and Aβ1–42. We can conclude that MS might play a key role in the apparition and development of cognitive disorders, including AD. We propose that metabolic theory is important to explain the apparition of cognitive diseases.

1 October 1995 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
EZEdgar Zenteno
Edgar Zenteno
JWJean Michel Wieruszeski
Jean Michel Wieruszeski
JMJean Montreuil
Jean Montreuil
HDHenri Debray
Henri Debray
LVLorena Vázquez
Lorena Vázquez
FCFélix Córdoba
Félix Córdoba